Monte Rosa Therapeutics
GLUE
#7469
Rank
NZ$0.52 B
Marketcap
$8.26
Share price
-2.57%
Change (1 day)
-12.52%
Change (1 year)

Monte Rosa Therapeutics (GLUE) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : NZ$0.36 Billion

According to Monte Rosa Therapeutics's latest financial reports the company's total liabilities are NZ$0.36 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Monte Rosa Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.38 B94.35%
2023-12-31NZ$0.19 B76.11%
2022-12-31NZ$0.11 B305.86%
2021-12-31NZ$27.54 M-79.74%
2020-12-31NZ$0.13 B293.99%
2019-12-31NZ$34.51 M